Cefbuperazone Sodium

头孢拉宗钠

Report date: 2024/01/18 09:59:32
NME

Base Information

Drug NameCefbuperazone Sodium
Drug Alias Name头孢拉宗CefbuperazonumCefbuperazonaTomiporanKeiperazon +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsInflammationEndocarditisVulvar Vestibulitis +[20] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1985/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesToyama Chemical Co LtdHaikou Pharmaceutical Factory Co LtdGuilin Pharmaceutical Co Ltd +[6] 
Inactive CompaniesHainan General Sanyang Pharmaceutical Co Ltd
Active IndicationsInflammationEndocarditisVulvar Vestibulitis +[19] 
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeJ01DC13
Related LinksWikipediaDrugBankKEGG